TARO-DEFERASIROX (TYPE J)
Identification of Taro-Deferasirox (Type J)
Please sign up for a free trial to see the description of this product.
Examples of the descriptions of OTHER drugs:
Lipitor 10 mg
Apo-Irbesartan 150 mg
Crestor 20 mg
Google image searchProduct monograph
Active ingredient
deferasirox, 180 MG
DIN: 02507323
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: TARO PHARMACEUTICALS INC
Date: 04-MAR-2021
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AC — Iron chelating agents (ATC, ATC/DDD)
- V03AC03 — DEFERASIROX (ATC/DDD)
Reference brand drug: Exjade
External Links for Taro-Deferasirox (Type J)
Search on Google
- Taro-Deferasirox (Type J) side effects
- Taro-Deferasirox (Type J) dosage
- deferasirox side effects
- deferasirox dosage
Taro Pharmaceuticals Inc
Go to Taro website to see drug product details. Sometimes you can find taro-deferasirox (type j) photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.
